Oliver

Alzheimer Drug Fails Trial

If you read the study results closely, the improvements noted did not mean the patients improved at all, but that they declined less rapidly than the control patients. If BAP can remove the "plaque", it needs to be done very early in the disease so as not to cause "Brain Swelling"...so, BAP may be helpful in the very early stages to prevent AD, or stop it early. But, I think what we're seeing is that if too much plaque is removed, it becomes very dangerous and risky.
What about Perispinal Etanercept? Why wasn't this studied since the results of the Phase I clinical trial showed actual improvements in Cognitive Ability and has maintained the progression of the disease in some patients for over 3 years? Somebody needs to get on this!